
Neurophth
Dedicated to discovering and developing gene therapies for patients suffering from blindness and other eye diseases globally.
Employees
Enterprise value
$481m
Authorizing premium user...
Dedicated to discovering and developing gene therapies for patients suffering from blindness and other eye diseases globally.